Dana-Farber Cancer Institute · 8 hours ago
Antibody Discovery & Engineering Scientist I/II – CAR-T Cell & Antibody Therapies
Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. The Scientist I role involves performing scientific experiments under the supervision of senior staff, contributing technical proficiency and scientific creativity, and working on problems requiring independent judgment.
CommunitiesHealth CareHealth DiagnosticsHospitalNon ProfitOncology
Responsibilities
Demonstrates potential for technical proficiency, scientific creativity, collaboration with others and independent thought
Works on problems of moderate scope in which analysis of situation or data requires a review of identifiable factors
Exercises judgment within defined procedures and practices to determine appropriate action
Works under general supervision. Latitude for independent judgment
Qualification
Required
Demonstrates potential for technical proficiency, scientific creativity, collaboration with others and independent thought
Works on problems of moderate scope in which analysis of situation or data requires a review of identifiable factors
Exercises judgment within defined procedures and practices to determine appropriate action
Works under general supervision. Latitude for independent judgment
Moderate skills with high level of proficiency. May consult with senior peers on general projects
Advanced degree preferred
Four to five years experience post bachelors degree preferred
Company
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute is a center dedicated to carrying out adult and pediatric cancer treatment activities and advanced research.
H1B Sponsorship
Dana-Farber Cancer Institute has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (191)
2024 (145)
2023 (155)
2022 (139)
2021 (105)
2020 (113)
Funding
Current Stage
Late StageTotal Funding
$88.08MKey Investors
Elaine and Eduardo Saverin FoundationThe DeGregorio Family FoundationLlama
2025-11-24Grant· $20M
2025-05-06Grant· $1M
2024-09-24Grant· $0.5M
Recent News
Medical Xpress - latest medical and health news stories
2025-12-29
MarketScreener
2025-12-16
Company data provided by crunchbase